Nexscient, Inc.
NXNTdata completeness 75%2 fiscal years on fileData notes: no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'epsDiluted'; no data for concept 'incomeTaxExpense'; no data for concept 'pretaxIncome'
Nexscient, Inc. earns about -1146% on equity, but has diluted owners by 4% over 2 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2024 | FY 2025 |
|---|---|---|
| Revenue | $01 | $01 |
| Net income | −$937,5922 | −$529,7042 |
| Operating cash flow | −$645,4523 | −$407,8343 |
| Capital expenditure | — | — |
| Free cash flow (derived) | — | — |
| Total debt | — | — |
| Cash & equivalents | $75,8044 | $100,4704 |
| Diluted shares | 20.4M | 21.3M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$0.12 of net worth that earned you −$0.25 last year.
It earned an average -1146% on equity over 2 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 4% over 2 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2024-06-30 · accession 0001477932-25-007240 (Revenues)
- 10-K · period ending 2024-06-30 · accession 0001477932-25-007240 (NetIncomeLoss)
- 10-K · period ending 2024-06-30 · accession 0001477932-25-007240 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-06-30 · accession 0001477932-25-007240 (CashAndCashEquivalentsAtCarryingValue)